Kyn Therapeutics is a clinical-stage biotechnology company developing new immunometabolic therapies for cancer. Kyn Therapeutics is advancing development candidates that modulate targets strongly implicated in immunosuppression across a range of tumor types and via multiple immune cell effects.
